COVID-19 Response to Cancer Conference

J Registry Manag. 2022 Summer;49(2):62-63.

Author

Cheryl Sheridan¹

Affiliation

¹ Sarah Cannon, the Cancer Institute of HCA Healthcare.

PMID: 37261200
PMCID: PMC10198390

No abstract available

MeSH terms

COVID-19* / epidemiology
Humans
Neoplasms* / epidemiology
Neoplasms* / therapy
SARS-CoV-2